即用型植入物桥接尿道缺损:从实验室到临床的多中心八年历程
本研究用液体胶原工程化无细胞补片以重建尿道,替代自体组织移植的现行手术实践。在69只雄性新西兰兔中优化设计后,最终TissueSpan原型植入9只兔的2 cm尿道缺损和6只犬的4 cm缺损;两种动物模型术后1个月均显示尿道通畅,补片在1-3个月内吸收,并出现尿路上皮自发性覆盖和平滑肌细胞迁移。随后启动首次人体临床试验;作者认为该无细胞补片可能成为替代尿道成形术的即用型产品,但仍需大规模临床试验进一步确认安全性、性能和患者获益。
要点
- 无细胞补片用液体胶原工程化制成,旨在替代自体组织移植行尿道重建。
- 69只雄性新西兰兔用于优化设计;最终原型植入9只兔2 cm缺损和6只犬4 cm缺损。
- 两种动物模型术后1个月尿道通畅,补片1-3个月内吸收,4 cm缺损也见尿路上皮覆盖和平滑肌细胞迁移。
核心结论
- 作者认为无细胞补片可能有潜力成为替代尿道成形术的即用型产品。
- 作者指出仍需大规模临床试验进一步确认该新医疗器械的安全性、性能和患者获益。
研究设计与样本
- 工程化无细胞补片由液体胶原制成,经体外、力学和外科医生台架测试。
- 69只雄性新西兰兔用于优化设计;最终TissueSpan原型植入9只兔的2 cm尿道缺损和6只犬的4 cm尿道缺损。
- 随后启动首次人体临床试验。
主要发现
- TissueSpan技术平台可制造不同直径和厚度的管状与矩形补片。
- 管状补片作为物理导管桥接尿道缺损,两种动物模型术后1个月均显示尿道通畅。
- 补片在1-3个月内吸收,即使4 cm长尿道缺损也显示补片自发性尿路上皮覆盖和平滑肌细胞迁移至手术区域。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者指出仍需大规模临床试验进一步确认该新医疗器械的安全性、性能和患者获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To engineer an acellular mesh to reconstruct the urethra to replace the current surgical practice of using autologous tissue grafts. Cell based approaches have shown progress. However, these have been associated with high costs and logistical challenges. MATERIALS AND METHODS: Acellular meshes were engineered using liquid collagen. They underwent in vitro, mechanical and bench testing by surgeons. Sixty-nine male New Zealand rabbits were used to refine the design. The final prototype based on the TissueSpan patented technology was then implanted again in a 2 cm long urethral defect in 9 rabbits and in a 4 cm long defect in 6 dogs. RESULTS: The TissueSpan technology platform allows for the manufacturing of tubular and rectangular meshes in different diameters and thicknesses. The tubular mesh acted as physical conduit to gap the urethral defect with a patent urethra demonstrated after 1month in both animal models. The mesh was absorbed within 1-3months. Spontaneous urothelial coverage of the mesh and smooth muscle cell migration into the surgical area was demonstrated even in a 4 cm long urethral defect. A first in man clinical trial was subsequently initiated. CONCLUSION: The acellular mesh may have the potential to be an off-the-shelf product for substitution urethroplasty. Its mechanical properties allow surgeons to easily create a physical conduit while its material properties favor tissue remodeling. A large-scale clinical trial is still required to further confirm the safety, performance, and patient benefit of this new medical device.
引用
- Vythilingam G, Larsson HM, Yeoh WS, et al. Off-the-Shelf Implant to Bridge a Urethral Defect: Multicenter 8-Year Journey From Bench to Bed. Urology. 2024. PMID: 39710073. doi:10.1016/j.urology.2024.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。